EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Proteasome Inhibitor MG132 Facilitates Antiviral Effects by Inhibiting TFEB Degradation and Activating Autophagy

Naiyu Liu, Yingrui Wei, Shanshan Fu, Kaiyue Zuo, Xinjie Zhu iD

ACS Omega · 10.11.2026 · 11 (44) · 68144-68154

DOI: 10.1021/acsomega.6c00932 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 28.10.2026. Verfasst von Naiyu Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hainan Province, Hainan University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ubiquitin-proteasome system, which serves as one of the most common cellular degradation pathways, plays a critical role in maintaining proteostasis. Yet, the correlation between the ubiquitin-proteasome system and antiviral defense remains to be defined. In this work, pharmacological inhibition of proteasomes via treatment with MG132, which inhibited proteasome activity during viral infection, facilitated antiviral effects in vitro. Similar to MG132, another proteasome inhibitor, bortezomib, effectively inhibited proteasome activity and exhibited antiviral effects. Guided by these findings, further assays demonstrated that MG132 blocked viral adsorption and internalization, which partially contributed to the antiviral effects. Meanwhile, MG132 inhibited TFEB degradation and promoted dephosphorylation of TFEB at Ser211, resulting in autophagy, which was associated with antiviral effects. Taken together, a key discovery of our study is the critical role of the proteasome inhibitor MG132 in promoting antiviral activity, providing valuable insights for the development of more effective antiviral strategies based on the autophagy signaling pathway mediated by TFEB.

Autor:innen und Institutionen

  • Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.
  • Li Song's Academician Workstation of Hainan University (School of Pharmaceutical Sciences), Hainan University, Sanya 572000, China.

ORCID-Profile: Xinjie Zhu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hainan Province
  • Hainan University

Zitieren

APA

Liu, N., Wei, Y., Fu, S., Zuo, K., & Zhu, X. (2026). Proteasome Inhibitor MG132 Facilitates Antiviral Effects by Inhibiting TFEB Degradation and Activating Autophagy. ACS Omega, 11(44), 68144-68154. https://doi.org/10.1021/acsomega.6c00932

Vancouver

Liu N, Wei Y, Fu S, Zuo K, Zhu X. Proteasome Inhibitor MG132 Facilitates Antiviral Effects by Inhibiting TFEB Degradation and Activating Autophagy. ACS Omega. 2026;11(44):68144-68154. doi:10.1021/acsomega.6c00932

BibTeX
@article{Liu2026,
  author = {Liu, Naiyu and Wei, Yingrui and Fu, Shanshan and Zuo, Kaiyue and Zhu, Xinjie},
  title = {Proteasome Inhibitor MG132 Facilitates Antiviral Effects by Inhibiting TFEB Degradation and Activating Autophagy},
  journal = {ACS Omega},
  year = {2026},
  volume = {11},
  number = {44},
  pages = {68144--68154},
  doi = {10.1021/acsomega.6c00932}
}
Kostenlos starten →